RadNet Expands AI Imaging Ambitions with Gleamer Acquisition

The €230m acquisition of French AI firm Gleamer expands DeepHealth’s imaging AI portfolio across key modalities including X-ray, CT, MRI and mammography.

ECR 2026: Bracco Showcases AI-Powered Brain MRI Solution AiMIFY

Bracco explores how AI can complement contrast media in next-generation imaging workflows

Prof. Minerva Becker on Imaging, AI and the Vision Behind ECR 2026

In our interview, ECR 2026 President Prof. Minerva Becker shares her vision for “Rays of Knowledge,” education, AI and the future of imaging.

Radiology under pressure: lessons from disaster, war and cyberattacks at ECR 2026

Radiology leaders at ECR 2026 shared frontline lessons on how imaging departments can prepare for and respond to disasters.

ECR 2026: Bayer Advances Precision Diagnostics with New Molecular Imaging Agents

New radiodiagnostic tracers aim to enable earlier and more precise detection of diseases such as cardiac amyloidosis

Bayer Presents New Data for Contrast Agent Gadoquatrane from Phase III Program at ECR 2026

New analyses show Bayer’s investigational MRI contrast agent delivers non-inferior diagnostic performance while reducing gadolinium dose by 60%.